CD8A and neoplasm: Supporting all these reports about Th cells, several studies carried out in melanoma [459] and CRC [460] in the last 5 years have demonstrated that these cells are capable of driving and sustaining meaningful anti-tumour immune responses, as well as supporting anti-tumour CD8+ T cell responses.